Umdlavuza wesibindi
Eminyakeni engamashumi amabili edlule, isibalo sabantu abashonile esidalwa ngumdlavuza wesibindi sikhuphuke ngama-80%, saba ngesinye sezimbangela ezikhula ngokushesha kakhulu zomdlavuza emhlabeni jikelele.
Ukufa komdlavuza wesibindi kubeka isibili emhlabeni ngokufa komdlavuza
According to the “Global Burden of Disease Study”, 830,000 people died of liver cancer in 2016, compared with 464,000 in 1990. This makes umdlavuza wesibindi the second leading cause of cancer death worldwide. The first is umdlavuza wamaphaphu. Umdlavuza wesibindi oyinhloko umdlavuza wesibindi ovame kakhulu emhlabeni futhi ungabangelwa ukuphuza kakhulu nezinye izindlela zokuphila, kodwa imbangela evame kakhulu ukutheleleka isikhathi eside nge-hepatitis B noma i-hepatitis C. Lawa magciwane ayinselelo enkulu yezempilo yomphakathi, ethinta abantu abangaphezu kwezigidi ezingama-325 emhlabeni jikelele.
Patients with limited treatment methods are very embarrassed. Once hepatocellular carcinoma (abbreviated as hepatocellular carcinoma) is diagnosed as advanced stage, portal vein isisu i-thrombus noma i-metastasis ekude ivame ukuhlotshaniswa nayo, futhi ithuba lokuhlinzwa liyalahleka. Isimo seziguli ezinomdlavuza wesibindi sibi, kanti izinga lokusinda leminyaka emi-5 licishe libe yi-12%. Ukushona nomdlavuza wamaphaphu kuphezulu kakhulu, kodwa isizathu sokuthi kungani ukufa komdlavuza wesibindi kuseduze nomdlavuza wamaphaphu akukona ukugula okuphezulu, kodwa izindlela zokwelashwa ezinomkhawulo. Umdlavuza wesibindi cishe awuzweli emithini ye-chemotherapeutic kanye nezidakamizwa ezimbalwa ezihlosiwe. I-Sorafenib ibilokhu ilawula imakethe yomdlavuza wesibindi iminyaka eyishumi. Uma isiguli silahlekelwa ithuba lokuhlinzwa, i-sorafenib kuphela etholakalayo futhi izosheshe imelane Kakhulu, ungasebenzisa i-radiotherapy ukuze ukhulule izimpawu, ngakho-ke isimo seziguli ezinomdlavuza wesibindi sinamahloni kakhulu. Kwaze kwafika uZibandlela (December) wonyaka odlule ukwelashwa komdlavuza wesibindi eChina yephule ukubusa kwamanje kwe-sorafenib. Umuthi oqondiswe ku-Bayer wokulwa nesimila i-Regofenib (Baiwango) wagunyazwa ngokusemthethweni yi-China Food and Drug Administration (CFDA) Ezigulini ezine-hepatocellular carcinoma (HCC) ezike zelashwa ngaphambilini nge-sorafenib. Akwanele ukuthi iziguli ezinomdlavuza wesibindi okhula ngokushesha zimakethe kuphela izidakamizwa ezimbili ezihlosiwe. Ngakho-ke ingabe zikhona ezinye izindlela zokwelapha iziguli ezinomdlavuza wesibindi?
I-Proton therapy yokwelashwa komdlavuza wesibindi
Ukwelashwa kwe-Proton breaks the current status of liver cancer treatment and brings new hope to patients
Kungenzeka ukuthi ubungalwazi lolu hlobo lwenqubo ye-radiotherapy. Ukwelashwa kwayo kwe-parenchymal kuyindlela “esezingeni eliphezulu” ye-radiotherapy. Ngenxa yesimiso sokwelashwa esiyingqayizivele se-proton therapy, ngeke ibe nemiphumela emibi eminingi njenge-radiotherapy evamile, futhi ilungele iziguli ezinomdlavuza wesibindi nganoma yisiphi isikhathi. Luhlobo luni lwesimiso sokwelashwa?
I-proton iyizinhlayiyana lapho i-athomu ye-hydrogen ilahlekelwa i-electron. I-Proton therapy ukusebenzisa i-cyclotron noma i-synchrotron ukusheshisa i-electron nucleus ifinyelele isivinini sokukhanya esingaba ngu-70%. Ingena emzimbeni futhi ifinyelele kumaseli omdlavuza ngalesi sivinini esisheshayo. Endaweni ethile, isivinini siyehla ngokuzumayo bese siyama, kwakheka umthamo ophakeme obukhali ekugcineni kobubanzi, obizwa ngokuthi i-Bragg Peak, ekhulula amandla amakhulu futhi ibulale amaseli omdlavuza. Ukwelashwa kwe-proton kungavikela ngempumelelo izicubu ezizungezile ezijwayelekile ngasikhathi sinye, kube nemiphumela emibi emincane. Isibonelo, inhliziyo namaphaphu azungeze isibindi yizitho ezibaluleke kakhulu. I-Proton therapy isengaphatha ngempumelelo izimila ngenkathi ivikela imisebenzi yalezi zitho ezibalulekile noma izinhlaka. Ukwelashwa ngeke kube nomthelela, okuyi-radiotherapy evamile. akunakwenzeka.
Ukwelashwa kweProton kulula futhi kuyashesha ezigulini ngaphandle kokulaliswa esibhedlela
Isikhathi sokwelashwa kwe-proton singaba sifushane njengemizuzu emihlanu, kodwa isikhathi sokumisa somshini ne-laser beam sithatha cishe imizuzu engama-30. Kanye ngosuku, njalo ngoLwesihlanu, ngokuvamile izikhathi ezingu-15-40 inkambo yokwelashwa. Izinzuzo zokwelashwa kwe-proton zokwelashwa ngokushesha kwezimila zingase zingabi sobala, kepha inzuzo izoba sobala ngemuva kweminyaka embalwa, ikakhulukazi ezigulini ezisencane, ngoba ukwelashwa kwe-proton kunemiphumela emibi emincane futhi ngeke kubangele noma yimuphi umonakalo emzimbeni.
Ukwabelana ngempumelelo kwe-proton therapy yeziguli ezinomdlavuza wesibindi ezineminyaka engama-52
Isiguli kwatholakala ukuthi sinomdlavuza wesibindi ngenxa yobuhlungu obungaphezulu kwesisu futhi asikwazanga ukuhlinzwa. Ukwelashwa kokungenelela kwanikezwa kanye, futhi umphumela wawungemuhle. Xhumana ICancerFax ukuze uthole ukwelashwa okwengeziwe futhi uncome ukwelashwa kwe-proton okususelwa esimweni sesiguli. ICancerFax iqoqa wonke amarekhodi ezokwelapha esiguli futhi iwahambise kochwepheshe abaziwayo basekhaya. Ngemuva kokubonisana okuhlukahlukene, iziguli zingahlehliswa.
Usayizi wesimila wawucishe ube ngu-10.93 * 11.16cm ngaphambi kokwelashwa kwe-proton, cishe u-10.43 * 10.19cm ngemva kwenyanga eyodwa yokwelashwa kwe-proton; cishe u-860.06cm3 ngaphambi kokwelashwa kwe-proton, cishe u-702.69cm3 ngemva kwenyanga eyodwa yokwelashwa kwe-proton, kanye ne-157.37cm3 yokushwabana kwesimila, Izimpawu zaba ngcono kakhulu. Ezinyangeni ezintathu kamuva, isimila sisancipha. Isiguli asinayo eminye imiphumela emibi futhi singaphila impilo evamile.
Ngubani ofanele ukwelashwa kwe-proton?
The application of proton therapy is very wide. In addition to liver cancer, proton therapy covers almost all solid tumors of the body (as shown below), such as lung cancer, brain cancer, umdlavuza wesibeletho, etc. For inoperable patients, patients who are intolerant to chemotherapy and radiotherapy, and have no other treatment options, proton therapy brings hope to many patients with solid tumors. Due to the almost zero side effects, proton therapy will be of great concern. Expect proton therapy to shine in the cancer field.
Kuthiwani uma udinga i-proton therapy?
ICancerFax ihlangene nesikhungo se-proton esidume umhlaba wonke ukuze kwakhiwe isikhungo esigunyaziwe sokuhlola i-proton therapy yasekhaya, esingaxhuma iziguli ngokwelashwa kwe-proton okufanele kakhulu emhlabeni, sisize iziguli ekuhloleni nasekwelashweni. I-United States, i-India, iJalimane, iJapan, iTaiwan kanye nezwe laseChina banezikhungo ezigunyaziwe zokwelapha i-proton, ungakhetha ngokwezidingo zakho! Kodwa-ke, noma ngabe uya kuphi ukuthola ukwelashwa kwe-proton, udinga ukuletha amarekhodi ezokwelapha ukuze ahlolwe. Iziguli ezinenkinga yokubonisana nobuso zingaqhuba ukubonisana nochwepheshe abakude ukuze bahlole ukuthi bayahlangabezana yini nezidingo zokwelashwa.
